0001104659-15-043306.txt : 20150604 0001104659-15-043306.hdr.sgml : 20150604 20150604073217 ACCESSION NUMBER: 0001104659-15-043306 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20150604 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150604 DATE AS OF CHANGE: 20150604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 15911842 BUSINESS ADDRESS: STREET 1: 4800 SCOTTSDALE ROAD STREET 2: SUITE 4400 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 BUSINESS PHONE: 602-572-6050 MAIL ADDRESS: STREET 1: 4800 SCOTTSDALE ROAD STREET 2: SUITE 4400 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 8-K 1 a15-13465_18k.htm 8-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):

June 4, 2015

 

MAGELLAN HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

 

DELAWARE

 

1-6639

 

58-1076937

(State or Other Jurisdiction

 

(Commission File

 

(IRS Employer

of Incorporation)

 

Number)

 

Identification No.)

 

4800 Scottsdale Road, Suite 4400

 

 

Scottsdale, Arizona

 

85251

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (602) 572-6050

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02.                   DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS.

 

Magellan Health, Inc. (“Magellan”) announced today that effective July 1, 2015, NIA Magellan, its specialty benefits management division, will be integrated into Magellan Healthcare, with Sam Srivastava, the CEO of Magellan Healthcare, leading the integration and the newly combined business unit. Tina Blasi, CEO of NIA Magellan, will remain employed until June 30, 2015 to provide strategic support on the transition and integration of the business units. Effective on June 30, 2015, Ms. Blasi’s employment will be terminated without cause.

 

Attached and incorporated herein by reference as Exhibit 99.1 is a copy of the press release dated June 4, 2015.

 

Item 9.01.                     Financial Statements, Pro Forma Financial Information and Exhibits

 

(a)  Financial Statements of business acquired:                                    Not applicable.

 

(b)  Pro forma financial information:                                                                                         Not applicable.

 

(d)  Exhibits:

 

Exhibit No.

 

Description

99.1

 

Registrant’s press release dated June 4, 2015.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MAGELLAN HEALTH, INC.

 

 

 

 

 

Date: June 4, 2015

By:

/s/ Jonathan N. Rubin

 

 

Name: Jonathan N. Rubin

 

 

Title: Executive Vice President and Chief Financial Officer

 

3


EX-99.1 2 a15-13465_1ex99d1.htm EX-99.1

Exhibit 99.1

 

 

NEWS RELEASE

Media Contact: Colleen Flanagan Johnson, cefjohnson@magellanhealth.com, (860) 507-1923

Investor Contact: Renie Shapiro Silver, rshapiro@magellanhealth.com, (877) 645-6464

 

Magellan Health Announces New Business Unit Alignment

and Business CEO Transitions

 

Scottsdale, Ariz. — June 4, 2015 — Magellan Health, Inc. (NASDAQ: MGLN) today announced that in order to further focus and advance its two growth initiatives — Magellan Complete Care and Magellan Rx Management — the company will be organized into two primary business units going forward — Magellan Healthcare and Magellan Rx Management. Effective July 1, NIA Magellan will be integrated into Magellan Healthcare to allow the combined business unit to focus more broadly on integrated care management for special populations, as well as specialty areas of healthcare.

 

“Bringing NIA Magellan and Magellan Healthcare together will better enable us to offer bundled healthcare management products and services, and provide additional value to customers and members through enhanced analytics and differentiated clinical models of care,” said Barry M. Smith, chairman and chief executive officer of Magellan Health. “Our focus on our customers’ unique needs will drive the most beneficial and customized solutions across our Healthcare business.”

 

Sam Srivastava, CEO of Magellan Healthcare, will lead NIA Magellan’s integration and the subsequent combined business unit. Tina Blasi, CEO of NIA Magellan, will remain at Magellan until the end of June to provide strategic support on the transition and integration of NIA Magellan into Magellan Healthcare.

 

“Under Tina’s leadership, NIA Magellan has grown significantly, evolving from a radiology management business to the broad specialty solutions manager it is today — addressing cutting-edge and high-cost areas of healthcare in order to improve quality of care and affordability,” said Smith. “We are incredibly grateful for Tina’s strong leadership over the past several years. She has been a driving force in both Magellan’s and NIA’s overall strategy, and we greatly appreciate all of her contributions.”

 

Magellan also announced that Bob Field, CEO of Magellan Rx Management, has decided to retire at the end of 2015, and named Mostafa Kamal, current general manager and senior vice president of Magellan Rx Management’s specialty division, as the new CEO, effective July 1. Field will work with Kamal to ensure a seamless transition for employees and customers.

 

“Since the acquisition of Partners Rx at the end of 2013, Bob has been clear about his plans to retire in the near future. As such, we have been thoughtfully planning for his succession for some time. Bob has been instrumental in driving our pharmacy strategy and growth. Today, our pharmacy business is more competitive, integrated and better able to serve its customers as a result of Bob’s leadership,” said Smith.

 



 

“In addition, Bob’s vision for Magellan Rx Management has helped us create a full-service PBM with a focus on outstanding customer service.”

 

Prior to being named CEO of Magellan Rx Management, Kamal was senior vice president and general manager of Magellan Rx Management’s specialty pharmacy business, as well as chief underwriting officer. From 2011 to 2014, Kamal was vice president of pricing, underwriting and analytics. Before joining Magellan, Kamal was director of strategy and analytics at Medco Health Solutions, Inc. As CEO, Kamal brings with him a deep understanding of strategy, corporate risk, pricing, sales and account management and operations.

 

“We are fortunate to have broad talent and bench strength across our businesses and are pleased that Sam Srivastava and Mostafa Kamal will be leading these businesses into the future,” Smith added.

 

About Magellan Health: Headquartered in Scottsdale, Ariz., Magellan Health, Inc. is a healthcare management company that focuses on fast-growing, complex and high-cost areas of healthcare, with an emphasis on special population management. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. Magellan’s customers include health plans, managed care organizations, insurance companies, employers, labor unions, various military and government agencies, third-party administrators, consultants and brokers. For more information, visit MagellanHealth.com.

 

###

 


GRAPHIC 3 g134651mmi001.jpg GRAPHIC begin 644 g134651mmi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#TC6_%UCH- MZMIE^/])U9&,$5PKI]Z-U4,/?K7"/X4TV09C\V//3:_%5 MU\,3V4ZW&GWY21#QO7_.:\:&.A?WCT*N&H2@U3?++S/6(-/J*M-<2/QG`/I67-CYUVX64.E^J_,Y M:.'YZ>N_7U)9_B)I,%Q)$(+J38Q7>BK@_3FF?\+(TG_GTO/^^5_^*K@CJ-K9 MZK<:=J<"/'&Y5)PN"!GC./YUL_V+I\R!XPVUAD,C\$5[].6&DMF>;B56PTK3 M6G1]&=$_Q+TF-=QM+T_15_\`BJN-XYTU(O->&X1<9.X+Q^M<>GA>WN91&DTB MCJ-*$TO4Y_;5N1U(QNCLG^*. MBJQ`M;Q@/X@BX/\`X]6I!XQLIX4E^RW*;AD!@N1/^^A6@NKP1Z:?,GC#K\OWA^=>=+%XRH`_QJK?^,K6QMFN!8WDZIRPB520/7!-<3<>(84R+>,R'^\> M!6=)JEY>2+$TFU78`J@Q7U<,-.UY=#PU6JR>AV\?Q,TF10WV*]`/3*K_`/%4 M_P#X61I/_/I>?]\K_P#%5QMY;HMPRE!M/(XJL;6(]B/H:RI5<-**;3/H/[)Q M3BI0DG^!Z'9^/--O9&2.VNAM&265?\:M_P#"667_`#QG_(?XUY6;V?31)]B1 M9&/WMXS^59LWB35)@5,XC!ZA%`KS<16FZK5!^Z;4LKJJ*]JK,]E/BVQ49:*9 M1[A1_6JDWC_2(XF>))KAHR-Z1!24!_B/.,5XI)<33',LTDG^\Q->A>&-'2QT M8&:/][=#=(K=AV%70E4JD]J]=M85M[6*%/NQH%'T`KU M*\*:BG#J>&E4C-QGT):**H:QJL.CV)N9@6YPJ#JQKE-8QE-J,5JR]FDWKNVY M&?3->>7OC/5+D%8?+MD/]P9./J:/"*W%YXB29Y9'\I&9F9B>O05/,NAZ3RRK M"FZE1I61Z)GBN;N/&]E::E]@N+*[BE#A#N5<E='7+>-/#QU"V&HVBG[ M7;+G:/XU'./K457-1O$YL(J,JG+6V?X,ZH,",T9JK:W4KV.FHI,BBLS8J: MMJEMHVFSZA=DB&%=S;1DGV'O7(?\+;T3_GQO_P#OA/\`XJJ?Q9U&Y$5EI4*N M4G)E?:N=V.`/ZUQFF>"_$&K',&G21I_STF^1?UZUA.TJO?S M/0HOBQH3RJKVU[&I."[(I`_)LUV-I=V]];1W-M*LL,@W*ZG((KSC3?A&S(&U M34=I/6.W7_V8UWNBZ/:Z%IL>GV8<0IDC>V223DFKAS_:.7$K#)+V+U+TD@BC M+D$@>E5_[1B_N/\`D*LLH92#W%8^TB38>H.*523C:QQ,V0=R@^HS67K.OVVB M&(7$4S^;G!C`[?4UJ`84#VKE_'=OYFEPSCK%+S]#Q6CV.K"0A4K1A/9ENQ\8 M:7?3B',D#-POF@`$_4&MW->.5TWAGQ)>1WD&GSMYT#G8I;EE].:E2[GIXO*U M%<]'IT.]S7(S?$C2(9Y(OLUV^QBNY57!QZNWXM[93@G,DA'RH/4UTTX1DFY'!A:,)J4JFR/1=/\>66J7B6MII]])(_H MJX`]3\W`KJ,UEZ'X?LM!M?*M4)=OORM]YS_A[5IUG-QO[IS57!R_=K0YS5/' M&G:5J,MC-;W+R18W%%7'(SW-6M#\5Z?K\TD-LLL`99Y-A'JIZUZ#PL/9W6]CA59\UNA[%2T@I: M\TZA,T$@=::QVJ3Z>E>>Z_K7B+5VDMK/3KNWM=I MX;UN0<:5=?BF*L)X/U^3_F'.,_WF`KC5>LWI$]QY=@E"SJ:][H]<5U90RG(/ M0BJ.H:O'II7SK>9D;HZ@$9].M<;HVD^,](^6V5/*/6.60,OX<\?A7:PQ2WFG M*FI6Z+*ZXD1#D`^QKIYISCIH_,\6M0C1E\2DO)E#_A*[+_GC/^0_QH_X2NR_ MYXS_`)#_`!K$UC2'TV7GL:R+V7R;*:4'[J&O,EBL1&?(]QNG2Y7/ MH;3?$_1UD*?9+PX.,A5_^*J7_A9&D_\`/I>?]\K_`/%5Y-[U=A;=T]"C" M;M(^,8SY8GJ4VW&[%HHI*Q+"C-<_>>*4C9DMH"Y!(W.<"LR;Q'J,P M($BQ`_W%KBGCJ,=+W-HT9O4[(NH."0"?4TMW3=K6%4I\EM3R/XK?\C3!_UZ+_`.A-6%H4>(Y93W(45N_%;_D:8/\`KS7_ M`-":L_3XO)L8EQR1N/XUTR>A[N71O9]D;EC)OMPI.2IQ5AV"*6;H!FLVQE\N M?:>C\?C4^H2%8Q&#][D_2O)A@G6QBI+:6ORZG#G%58*$ZOS7J_\`@E1;F5)S M.CE7)SFN@L;Y+R/L)!]Y?ZUS-212O#()(V*L.E?>8C"0JP2CHUL?G>6YM5P= M5N3O%[K]?4RO&MOY.N^;C`FC##ZCC^E4=)UV\TN140F6$GF%CP?IZ5O>*C_: MNGVLT,9:>.38R#KS_3BET/P\ECBYNP'N.H7J$_\`KU\;BY/#5&I:,_4(U\-B M<*I.THO^OD:0\86=C#^[M97N6'SQO\NSO@FL6]\7ZQ=L=D_V=#T6(8Q^-EAU[; MS7<7F+/)Y^,D[S\U83O,&*N\@(X(+&NI''%4=0T\70\R,`3#\FKW7227NHZ% M=*Q@[CZM^=:&D2;)7[Y`S5!E9&*L,$'!![5;TT_OG'JM<\G971G5;4&T=".G M%6=.3S-0A'HV?RK/MY,C8?PK9T-`UT[_`-U/YT\572PLY^7_``#?"M59Q:-' M48\JLGIP:RKB41IM!^8_I6EJ^IV6GVZK=2A6F.V->I)_P]ZQ+A)8KAXYU99% M."#VKYG"0K5:/+!7/N,/CJ%&G:K*UB(U6NK-9@63Y9/7UJS1DUV4\JQ%[MI$ M5<^PEK)-_(B\-:.VHZXD,T3&.$>9(,=<=!^)KU6#2;N=AF/RT_O-_A61X#46 M4^V11ONESDCD8Z"N^%.ERZI.]G8\W$8Z4VG%6]3*@T&U4?O_`-^>N&''Y5JC M@44M;'G2G*;O)A6+XLL#?:')L4M)#^\0#VZ_I6U37`92",@\&@JE4=.:FNAX MY7;>`K?%K=71'+N$!]AUKE]:L3IFJSVQ^ZK;D]U/(KT+PY9BRT.VBVX9EWM] M3S6<5J?19G73PRY?M6_S-2@C-+2&M#YDQ?$UQ'I_AZ94PGF#RD`XZ_\`ULUY MQ'(T4BR(Q5U.5(Z@UUOCR\!>VLE/*YD;^0_K7(5]#E]-1HW?4^.S>NY8JR^R M>E^'=975M/4LP^TQC$J_U_&M@=*\GTO49M*ODN83]WAE[,/2O3["^@U&SCN; M=MR./R/<5YF,PSHSNOA?]6//P-;!JKJ4/VC3;F+KOB8?I5&E&7)4C+LT>2U MUG@[0VEE75+E2$0_N5/\1]:Q]`T676+Y4QM@B(,S'T]/K7IT<:11+&BA548` M`Z"HBNI]!F>,Y(^Q@]7OZ?\`!(KRTBOK.6UF+>7*I5MIP<&H=+TJRT>U6VLH M1&@Z^K'U)[U=HK2_0^*0VMUJNH/% M9PM-+([-A>V3U/H*]&\,^#H-&VW5RPFO<<$?=C]A_C6OI6AV&C1LEE`$W'YF M/+'\:T*ZJV)<_=CHC&%)+5[A2T45RFPE)3J*`$%%+10`4444`1S0QSQM'*@= M&'(-<#XOT"^@M733K:6XCE8<1C)4=\UZ%25E.E&'](6Z2Z73K=9HS MN5U3!!]:[(5N1W/+A@'":E&1+H]@NFZ3;6@`'E1@-CNW?]:NT4M8MW=V>FE8 M****0S&U/P_!=AI8,13'GCHWUKE;BVGM)?*GB,;=L]#]*]#JO=V4%[$8IXPR M]CW'TK@Q&"C4]Z.C-Z=9QT>QQ^A0&?5X>,B/+G\*[>LS3-$ATR9Y4D:1F&!N M["M,5>$HRI4[2W)JS4Y71Y-\3T\SQA:)C.ZV0?\`C[55X'`X%;WC>P67QC:7 M,\JQP?9@@;ONW-4D.E6D1!V>8WJQKJ:YM4>]@:T*=+71"P6:Y^4`=E[FN`AF>!MT9Q_6L959T MI7INTNYK6P]#'I?6(7BNAT1O)3V4?A33=-+*V:^EJ2C"#J3V1\1[!UY1@ MM[DE%7FLHU8J0P(/K3#9+V#_ M``,X$J01U%:HUFVT;1Y[HR*;B7Y84/.Y@.X].:ZFR\%:7!$KW+O=-C).=J_D M*I:SX:TO68/+:W2%D!$+Q#!3_$5XL,;3QJE2IWY5:[_0Y:%&I@I*57KT_4\G MO=0NK^Z-W=RF28G.3T'L!VKU^XLXM:T2WO$&ZY:!65EXW''(->5ZUH%]H4_E MW2;HV/R3+]U_\#[5Z1\/KS[3X5BB+9:VD:,CN!U'\ZZZ;=-^[I8]K#* MM':^OM/EBA9R9-DI7LO7FNE50JA5&`!@4M1W%U!:0-/<2+%&@R68X`HT1M.K M*<(TWTV)J0U3T[5K'5H6EL9Q,B':Q`(P?QJYUZ4M]C)Q<79GF?BJ?S_$-SSD M(0@_`5D`%FV@$GT`R:]*F\*:70,U>M-+L[%=MM:Q1#U"\U M[4B/4PF74L*^9.[`44"BN0](CG_U354JS M<'$>/4U6K6&QA4W+<+[T'/(J2J4;F-L]N]71R*B2LS2$KH6DQ2T5)9#!:P6R MLL$2QAF+$*,9/K4M+10-MMW84444""DI:*`$I:**`"BBB@`HHHH`****`"BB MB@`HHHH`*3%+10`4444`%%%%`!24M%`"8HI:*`/-OB/*?[9AA[>0K?JU9^A: MULQ:7`_#GGRC5[N/\`=)_J%;^(_P![ MZ5Z7+!89)QVN0:CKFKR3PVDODK^[CW?+P._/K4,'A/49#^],4 M(]VR?TKV#5O#Z7A,UL5CF[CLW_UZY:>WEMI3%-&4<=C7RF)J5J. M2[QQJ"BL0,]<5TL[^7!(_]U2:Y$$G)/>O M3R:'MN>=36UD<&-QU>FX\DVBVMZO\2$?2JFLW"WUI#IZ2A=TN\Y]`.GZU#+. M!E4Z^M8^IL?,CY.1DYS7J2HT/:+E6QYM7.:]>/L)--/J;%O:PVJ[8UY[L>IK MI=$A,=HTA',C>(P2E#]1[BO'P-?FC[.6Z M/L,%6YER/=#41I'"(,D]*TF:WTZT,DTBQQJ,LS>M9EQJMEH<0>X)>X(9;&W1QI\,)>1R<%CD`?0=?RKLG\,6Y.8YI5]C@UQ_P8M-MAJ5[MQYD MJQ@_09_K7IE=BHTZ'N4U9'@M>V7-4U9R]YX/%U`T,CQ3QMU21.*Y[2/!K^$[ M^>-;A3:WN#&A;)1AV]Q@UZ2>E<5KUY]JU-MC'9%\B_7O7-BZ[I4[QW>QT86D MH5+Q+J6R+][YC[US'B/3KJ662?39WAG3_EFK863\/6N@L+T3@1.?W@'_`'U5 M.Y.;F0_[5>-E;JU\1-5W?3Y;]#7'8B=%1G!ZW//XO$VJVLC1S[)"IP5D3!!_ M"NC\)^,_^)]!#-;[%F)1F5LCIGI^%1^(=`&I1_:+956Z7KVWCT^MH\/&G43L>KAJV'QM%M*SZKL?0D4J3('C8,IZ$4^N6LK][ M*;(RT9^\N:Z.VNHKJ(21-D'J.XKO/)K494WY$](:*1AD8H,##UWQ58:(K1LW MG7./EA0\CZGM7FVL:[?ZW.7NY3Y>?EA7A5_#O]:WM5\`ZFMQ+/:S)=!W+89L M/R<]ZY>[L;NQD*7=M+"P_OJ17F8B=5NS5D?69;1PL4I0DI2_+T1V_P`-"/)O MU[[U/Z5W(K@OAH26U#'3Y.?SKO177AOX2/$S3_>Y_+\A:***Z#S@HHHH`*2E MHH`@N$9E&`3@U"()#_#CZU=HJE)HAP3=RJ+8GJV/I5E1@8':EHI-MC44M@HH MHI%!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`?>) MM(N=,L9G16FB(P'49(^HKSV69B=O*#W&,U]!8JI7/=HP3^=5 MATL/!PALW@KV^_P#AYX?O,LD# MVK?],7P/R-+X;\%Z1H=S+=PG[7=,<"64#,8]!Z?6ME6C%^9PT<#4A.[V,7P+ M\.8-+BCU/685EOC\R0MRL'^)_E6QJMF+:[;Y1M?YE.*ZG%4]4M/M5HP4?.O* MUE-N;]X]S#25*5NAR9MXB>4IDGAN36;69;.X^RSQC]W*PW`-Z8JCB*GLX>[HV?.NMZ9J6DZI+;:K&Z7&LVM=1MDF0CY6(^9/<'M7BWB?X?:IH%XOE*UU932!(YD7 M)3)P`P[?6O2IU4]'H?.SI..J/4?AO9+9^![#"X,X,S>^XD_RQ745!86T=GI] MO:Q*%2&-44#L`*G-<E>7:WXP,@:VTPE5/#3D#^M>E3P4,+&ZUD]V>75Q7MZRA- M:&R_AB]NO]+MX%^UQ$,KJP^?'8UZ/1BJ>JLS>E#V,U.F[ M,YRUT2YF56G(AX&1U-;%GIT-G\T>XL1@DGK5O%%!U5*]2>C8"EI*6@Q$Q4<] MO#))4/577(-2T4`G;4KVEA:6"%+2WC@5CDA%QDU/2T4)6V&VV[L**** M!!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!24M(:` M*][/Y-NQ'#-P*HZ;*4N"A/#C]:34I2]QY?9!59',;JPZ@YKY'&8YK'*2V@[? MYG=3I_N[=SH**;&XD0..A&:=7UJ=U='"8DVEEM75L?N7.\^WM6V*BG9^+_`(5QR+-J'A_*2?>:S/W6 M_P!P]OI731J1BN5JQS5:;;YEJ>9Z>N;G=_=6NU\!WILO%EJ-Q"S@Q,/7(X_E M7*Z78W1GEA%M*9PVPQ!#N!^E=WX?\!ZV;ZWO+G;9)$X<;CES@],#I556CRVJ MDL0G%;6/5!2T@ZTMHJK) MI7_/.7_OH5I45Q5L!AJSO..II&I..S(K>,PP+&3DCO4HHP*6NJ$%"*C'9$-W M=R"Z^X/K56KTB!UP13%MT'49^IK>,DD92BVR&.9DX/(JW2*BKT4"G5#:944U MN%%%%(H****`(A!&LC2+&@=NK!1D_C4@Z44M`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 I10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!__]D_ ` end GRAPHIC 4 g134651mmi002.jpg GRAPHIC begin 644 g134651mmi002.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#H?B+X]U;P MGJUK:Z?';/'+#O;SD).`_&"^+=%\Z7RTOH&VW$2=!Z$9[$5Y_\:`& M\3Z:IZ&#!_[ZK/T]I?AM\18HFDD>RF"AB>-\3]"?=30,]TN)XK6WDN)W$<42 MEW8]``,DUXY=?&369-7>.PM[06;3!8O,1BQ3.,GGKWKH?B_XE:QT6+1K1P9M M0YDQU$0_Q/'X&O,]>\/'PY?:1;2[A<3P13S*?X69_N_@`*`/I%"2@)ZD9IU< MOXP\:0>#[&U=[26[GNB5AB3C)`R7YAD/8>A'KVQ7G]S\:7EN772M!EN(4/WV8[B/7`'%` M'JM%>1?\+ON),1QZ"/,)`YFR/RQ77^+?B#8>%+:%98C<7TZ!UMD.,#U)["@# MKJY7X@^)KWPKH$=_8QQ/*]PL9$H)&"">Q]JY6S^-.V[C75=$DMK>0_ZQ6)*C MUP1S^%7?B]020RW*.CCH05;!H`GO\`QUJMK\,K+Q,D5N;NXD56 M0J=@!8CCG/:N@\$:[=>(_"]OJ=XD:32LP81@A>#CO7G>K_\`)!-+_P"NR?\` MH;5TW@#4X=&^%<>I7`9HK82NP09)^8]*`.^HKR>3XSWS$R6_AJ3R.H9V/3Z@ M8KL/"GCBS\6Z9/-:1&*\MUS+;.GKQ^5<)\ M7E9O'5AA2<01=!_TT-`'<^-O&>E>%4MFFM$O-1*$P1\?(.Y)[#^=* M==\.3QWWAI(=/F`(N!`XV+?BEI>O^&[G2M-LKIY;A0"64`(`03TZ]*`,RV6XD^!%SY99E34,MCLF M5S^%=-\+-<\.6?A06TEW:VMXKLUP)6"L_/#9/48JGX"U1K#X5Z@8+!]0N(;B M0?91'NW;@,9'=?\`"O.M-_L:*\E'B6QOPKG*K;$1%#GGAAR*`.OTZ:UU/XU1 MS^'E7[(9=[LH^5@%^"2\M[:Y($*@'[HPHP>,=Z M[SP'K7@&VE%EH>;6[E&,W2XDD]MQZ_05S?C_`$&_\->,!XKLK075I)()'#)N M57Q@JP]#ZT`5O'7C_1?%FAK9P:5=0W,*615`7U'!]*BO+B2?X)6`D9F\K M43&I/8#=Q^M;Z?%GPJT(SX<)G(_U:Q1D9]C3O'ER^K_"VROX].^Q"2Y61H$3 M&P?,!D8^E`%#5_\`D@FE_P#79/\`T-JW?!VK:9HOPEAO-6"M;*T@,;#/F'>< M*!W-<]>3+??`BUC@#,]G<*DRXY4AR?ZBJ5SI]YJOP?L&LHWE_L^[D-S&H^90 M2><=\9_6@#7'Q/\`$6JM(="\*I-:)\I4QM(?Q*X'X54^#[R-XOU!@8I:* M`"HW@BD;<\:,?4J#4E%`#)(8YD,JL`0?PJ"'3;&V),%G!%GKLC`S5J MB@#F/'EW=Z-X-OKS2CY$\>T[XU&5&>37/^`]:L_&6A36WB6>ROKP2$&&6)%. MSL1Z_6O0YH8[B%X9HUDC<;61AD,/0BN#U+X.>'KRZ:XMIKFRW'/EQ,"@^@/3 M\Z`."^)&C^'-'U2U3PY,%N6)\VWA?P6^K-;)I&F:C$SWEY;J M9"0,!@HW9_&LKP]\,/#_`(?NA=A)+VX7E'N2&"'U`Z9IOBR>ZMO%6DS6=O\` M:+A8WV19QNY%:T8*M5 MM8\6V.G7S6#6DUVZ`%Q&H(7VK&6]U2]\9Z0VIZ>+-EWA`#G<,&G"^U6R\4ZP M=+TT7I=T\S)QMXXKIC0BK7[7W\[;G++$3:?+IK;;ROL=+HFHP:Q8O-'8M;1A M]I25`-WO5?2/$NG:EJD^G6L)C:/)W;0!)@X.,5$^LZC%X9O;[4[$6CL=\7=)BT444B@ MHHHH`****`"BBB@!*Q=1T>XNO$FFZE&R>5:JP<$\\^E;=%5&3B[HB<%-69B: MCI%Q=>)--U&,IY5J&$@)YY!Z5GW^B:_;ZSJZ-%9WT]JTGV@/(RD@&,=NG7-:&M^&;7 M4-&EM+:W@BFVCRWVXY'J16[11[>>EM+=A?5X6=];]SD]0T#6Y9-.O[*X@COK M6#RGW\J3CDCBG7>C^(=4\.75CJ,UJ]R[J8F3@8'7/%=513]O+31:"^K0UU>O MF8^MZ3<:CX:?3H603%$`+'C(Q_A4&M:):WZ*F- M64;6Z.Y